Barrett's oesophagus is a condition which predisposes towards development of
oesophageal adenocarcinoma, a highly lethal tumour which has been increasing in …

The incidence of adenocarcinoma of the distal esophagus is increasing at an alarming rate.
Intestinal metaplasia in the distal esophagus, ie Barrett's esophagus, has been identified as …

Background: Endoscopic therapy is increasingly being used for high-grade dysplasia (HGD)
and mucosal adenocarcinoma (BC) in patients with Barrett's esophagus. This report …

Esophageal adenocarcinoma and its precursor, Barrett's esophagus, are rapidly rising in
incidence. This review serves to highlight the role of pharmacologic, endoscopic, and …

Esophagectomy remains the treatment of choice for the appropriate patient with Barrett's
adenocarcinoma invading beyond the mucosa, without evidence of distant metastasis or …

Barrett's oesophagus is an acquired condition with columnar metaplasia ol the distal
oesophagus. This condition represents the most serious consequence of chronic gastro …

The normal squamous esophageal epithelium reacts as a chronic inflammation to the
severe gastro-esophageal reflux. Esophagitis will progress to Barrett metaplasia in 10% of …

The incidence of early esophageal adenocarcinoma has been increasing significantly in
recent decades. Prognosis depends greatly on the choice of treatment. Early cancers can be …

The field of Barrett's esophagus ablation has come a long way since the original pioneering
work of Brandt and Berenson in the early 1990s [1, 2]. In fact, ablation is now viewed as a …

The standard of care for treatment of Barrett's esophagus (BE) with early esophageal
neoplasia, including high-grade dysplasia (HGD) and intramucosal adenocarcinoma (IMC) …